Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small Pox”

88 trials

Showing 20 of 88 results

Testing effectiveness (Phase 2)Study completedNCT00857493
What this trial is testing

Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects

Who this might be right for
Smallpox
Bavarian Nordic 120
Testing effectiveness (Phase 2)Study completedNCT01668537
What this trial is testing

A Phase II Trial to Compare a Liquid-frozen and a Freeze-dried Formulation of IMVAMUNE (MVA-BN®) Smallpox Vaccine in Vaccinia-naïve Healthy Subjects

Who this might be right for
Smallpox
Bavarian Nordic 651
Testing effectiveness (Phase 2)Study completedNCT00133575
What this trial is testing

ACAM 3000 MVA at Harvard Medical School

Who this might be right for
Smallpox
National Institute of Allergy and Infectious Diseases (NIAID) 72
Early research (Phase 1)Study completedNCT00728689
What this trial is testing

Phase I Trial of an Investigational Small Pox Medication

Who this might be right for
Orthopoxviral DiseaseSmallpoxMonkey Pox
SIGA Technologies 12
Testing effectiveness (Phase 2)Study completedNCT00189904
What this trial is testing

Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients

Who this might be right for
HIV Infections
Bavarian Nordic 151
Testing effectiveness (Phase 2)Study completedNCT00686582
What this trial is testing

An Open-Label Phase II Study to Evaluate Immunogenicity and Safety of a Single IMVAMUNE Booster Vaccination Two Years After the Last IMVAMUNE Vaccination in Former POX-MVA-005 Vaccinees

Who this might be right for
Smallpox
Bavarian Nordic 304
Large-scale testing (Phase 3)Study completedNCT01143181
What this trial is testing

Study to Assess Brincidofovir Treatment of Serious Diseases or Conditions Caused by Double-stranded DNA Viruses

Who this might be right for
Double-stranded DNA Virus
Jazz Pharmaceuticals 210
Early research (Phase 1)Study completedNCT00079820
What this trial is testing

Safety, Tolerability, and Immune Response of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Adults

Who this might be right for
Smallpox
Sanofi Pasteur, a Sanofi Company 110
Not applicableStudy completedNCT01395082
What this trial is testing

ACAM2000® Myopericarditis Registry

Who this might be right for
MyocarditisPericarditis
Emergent BioSolutions 24
Post-approval studies (Phase 4)Active Not RecruitingNCT05745987
What this trial is testing

Smallpox Vaccine for Mpox Post-Exposure Prophylaxis: A Cluster RCT

Who this might be right for
Monkeypox
McMaster University 3,000
Not applicableStudy completedNCT00123396
What this trial is testing

VHA Clinicians and Bioterror Events: Interactive Web-based Learning

Who this might be right for
SmallpoxAnthrax
US Department of Veterans Affairs 15
Testing effectiveness (Phase 2)Study completedNCT00053495
What this trial is testing

Effect of Dose, Safety, Tolerability of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination

Who this might be right for
Smallpox
Emergent BioSolutions 353
Large-scale testing (Phase 3)Study completedNCT01158157
What this trial is testing

VA-006 Vaccinia Vaccine (ACAM2000) for the Production of VIGIV

Who this might be right for
Smallpox Vaccine Adverse Reaction
Emergent BioSolutions 25
Early research (Phase 1)Study completedNCT00068198
What this trial is testing

Human Immune Responses Smallpox

Who this might be right for
Smallpox
National Institute of Allergy and Infectious Diseases (NIAID) 45
Early research (Phase 1)Study completedNCT00000767
What this trial is testing

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB Env/Gag/Pol Vaccine (TBC-3B)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 18
Early research (Phase 1)WithdrawnNCT00389103
What this trial is testing

Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD)

Who this might be right for
SmallpoxAtopic Dermatitis
Sanofi Pasteur, a Sanofi Company
Testing effectiveness (Phase 2)Study completedNCT00189956
What this trial is testing

Dose-finding Study to Evaluate Immunogenicity of Three Different Dose Levels of the IMVAMUNE (MVA-BN) Smallpox Vaccine.

Who this might be right for
Smallpox
Bavarian Nordic 165
Large-scale testing (Phase 3)Study completedNCT04971109
What this trial is testing

Safety, Tolerability and Pharmacokinetics of TPOXX When Administered Orally for 28 Days

Who this might be right for
Smallpox
SIGA Technologies 467
Testing effectiveness (Phase 2)Study completedNCT00437021
What this trial is testing

MVA Post-Event: Administration Timing and Boost Study

Who this might be right for
Smallpox
National Institute of Allergy and Infectious Diseases (NIAID) 226
Testing effectiveness (Phase 2)Study completedNCT00038987
What this trial is testing

Vaccinia Virus Vaccine (APSV) in Vaccinia- Naive Subjects: PILOT

Who this might be right for
Smallpox
National Institute of Allergy and Infectious Diseases (NIAID) 330
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation